AbL Diagnostics (France) Price Prediction
| ABLD Stock | 2.84 0.02 0.70% |
Oversold Vs Overbought
45
Oversold | Overbought |
Using AbL Diagnostics hype-based prediction, you can estimate the value of AbL Diagnostics SA from the perspective of AbL Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in AbL Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying AbL because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AbL Diagnostics after-hype prediction price | EUR 2.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AbL |
AbL Diagnostics After-Hype Price Prediction Density Analysis
As far as predicting the price of AbL Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AbL Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AbL Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AbL Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting AbL Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AbL Diagnostics' historical news coverage. AbL Diagnostics' after-hype downside and upside margins for the prediction period are 2.17 and 3.51, respectively. We have considered AbL Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AbL Diagnostics is not too volatile at this time. Analysis and calculation of next after-hype price of AbL Diagnostics SA is based on 3 months time horizon.
AbL Diagnostics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as AbL Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AbL Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AbL Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 0.67 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.84 | 2.84 | 0.00 |
|
AbL Diagnostics Hype Timeline
AbL Diagnostics SA is presently traded for 2.84on Euronext Paris of France. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. AbL is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.04%. %. The volatility of related hype on AbL Diagnostics is about 0.0%, with the expected price after the next announcement by competition of 2.84. About 12.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.08. AbL Diagnostics SA last dividend was issued on the 1st of October 2020. The entity had 8:1 split on the 18th of May 2022. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out AbL Diagnostics Basic Forecasting Models to cross-verify your projections.AbL Diagnostics Related Hype Analysis
Having access to credible news sources related to AbL Diagnostics' direct competition is more important than ever and may enhance your ability to predict AbL Diagnostics' future price movements. Getting to know how AbL Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AbL Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AXW | Axway Software | 0.00 | 0 per month | 0.82 | 0.13 | 2.31 | (1.75) | 6.22 | |
| ALREW | Reworld Media | 0.00 | 0 per month | 0.00 | (0.23) | 3.69 | (5.08) | 24.16 | |
| MLNOV | Novatech Industries SA | 0.00 | 0 per month | 3.34 | 0 | 10.00 | (9.09) | 36.83 | |
| MLETA | Metalliance SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ALNMG | Netmedia Group SA | 0.00 | 0 per month | 0.00 | (0.14) | 5.49 | (8.11) | 22.86 | |
| JCQ | Jacquet Metal Service | 0.00 | 0 per month | 1.59 | (0.05) | 3.08 | (2.26) | 8.94 | |
| GTT | Gaztransport Technigaz SAS | 0.00 | 0 per month | 1.02 | (0.02) | 2.71 | (1.87) | 5.95 |
AbL Diagnostics Additional Predictive Modules
Most predictive techniques to examine AbL price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AbL using various technical indicators. When you analyze AbL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AbL Diagnostics Predictive Indicators
The successful prediction of AbL Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AbL Diagnostics SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AbL Diagnostics based on analysis of AbL Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AbL Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AbL Diagnostics's related companies.
Story Coverage note for AbL Diagnostics
The number of cover stories for AbL Diagnostics depends on current market conditions and AbL Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AbL Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AbL Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
AbL Diagnostics Short Properties
AbL Diagnostics' future price predictability will typically decrease when AbL Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AbL Diagnostics SA often depends not only on the future outlook of the potential AbL Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AbL Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2 M | |
| Cash And Short Term Investments | 2.7 M | |
| Shares Float | 2 M |
Complementary Tools for AbL Stock analysis
When running AbL Diagnostics' price analysis, check to measure AbL Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbL Diagnostics is operating at the current time. Most of AbL Diagnostics' value examination focuses on studying past and present price action to predict the probability of AbL Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbL Diagnostics' price. Additionally, you may evaluate how the addition of AbL Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |